Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [338]

Editor's ASCO 2016 Roundup

Prof Gordon McVie - ecancer Editor in Chief

Editor's ASCO 2016 Roundup ( Prof Gordon McVie - ecancer Editor in Chief )

Chemotherapy combination with capecitabine extends survival after pancreatic...

Prof John Neoptolemos - University of Liverpool, Liverpool, UK

Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery ( Prof John Neoptolemos - University of Liverpool, Liverpool, UK )

METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA

METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )

Advanced hepatocellular carcinoma and personalised therapy

Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA

Advanced hepatocellular carcinoma and personalised therapy ( Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )

Latest in hepatocellular carcinoma treatments

Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA

Latest in hepatocellular carcinoma treatments ( Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )

Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine...

Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK

Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma ( Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK )

Direct activation of STING in the tumour microenvironment leads to potent and...

Dr Thomas Dubensky - Aduro Biotech, Berkley, USA

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity ( Dr Thomas Dubensky - Aduro Biotech, Berkley, USA )

Understanding personalised medicine - the e-learning course

Prof Gordon McVie

Understanding personalised medicine - the e-learning course ( Prof Gordon McVie )

p62: Metabolism and the tumour microenvironment

Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La...

p62: Metabolism and the tumour microenvironment ( Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA )

Editor's Choice for April 2016

Prof Gordon McVie - ecancer Editor

Editor's Choice for April 2016 ( Prof Gordon McVie - ecancer Editor )

Targeting AFP in hepatocellular cancer

Dr Lisa Butterfield University of Pittsburgh, Pittsburgh, USA

Targeting AFP in hepatocellular cancer ( Dr Lisa Butterfield University of Pittsburgh, Pittsburgh, USA )

Patient perspective on immunotherapy and the ITOC-3 conference

Peter Trayhurn - Patient advocate

Patient perspective on immunotherapy and the ITOC-3 conference ( Peter Trayhurn - Patient advocate )

More from ecancer